arrow
L

Liming Tao

Anhui Medical University
H指数:27
被引数:2,809

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Global; regional; and national trends in DALYs for blindness and vision loss in teenagers and young adults; 1990–2019: an age-period-cohort analysis based on the Global Burden of Disease Study 2019

全球、区域和国家层面的失明与视力丧失所致伤残调整生命年(DALYs)在青少年和青年人群中的趋势,1990–2019年:一项基于全球疾病负担研究2019的年龄-时期-队列分析

2025-10-290
OAAI
Efficacy and Safety of Efdamrofusp Alfa versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration A Randomized, Double-Masked, Active-Controlled, Noninferiority, Phase II Trial

Efdamrofusp alfa与Aflibercept在新生血管性年龄相关性黄斑变性患者中的疗效与安全性:一项随机、双盲、活性对照、非劣效性、II期临床试验

2025-02-010
PRE
Association of retinopathy with risk of all-cause and specific-cause mortality in the National Health and Nutrition Examination Survey, 2005 to 2008

2008年2005年全国健康和营养检查调查中视网膜病变与全因和特定原因死亡风险的关系

2023-08-235
OAAI